Clinical Trial Update: A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetics study evaluated potential drug interactions of the HL-040XC fixed-dose combination tablet in healthy male subjects, in the context…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• HL-040XC

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Hypertension, Hyperlipidemia | Phase 1 | Status: COMPLETED